Clinical Trial Update: A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating camlipixant versus placebo for abdominal symptoms in adults with irritable bowel syndrome (IBS-D and IBS-M); the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Camlipixant (camlipixant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: NOT_YET_RECRUITING